Compare
Bodhi Tree Biotechnology Inc vs Wenyuan Group Corp. vs Hestia Insight Inc. vs Radiant Strategies Corp
| Latest fiscal year | Bodhi Tree Biotechnology Inc BDTB | Wenyuan Group Corp. WYGC | Hestia Insight Inc. HSTA | Radiant Strategies Corp RDSC |
|---|---|---|---|---|
| Year ended | 2025-09-30 | 2025-12-31 | 2025-11-30 | 2026-04-30 |
| Revenue | $17.0K | $24.6K | $8.0K | $40.3K |
| Revenue growth (YoY) | n/a | -59.1% | -99.4% | n/a |
| Gross margin | n/a | -57.5% | n/a | 99.0% |
| Operating margin | -868.3% | n/m | n/m | -61.0% |
| Net margin | -880.4% | n/m | n/m | -58.7% |
| Net income | -$149.7K | -$639.0K | -$943.4K | -$23.6K |
| EPS (Diluted) | -$0.01 | -$0.01 | $0.02 | $0.00 |
| Operating cash flow | -$150.2K | -$197.6K | -$134.3K | -$26.1K |
| Free cash flow | n/a | n/a | n/a | -$61.7K |
| Cash & equivalents | n/a | $144 | n/a | $14.7K |
| Total assets | $119.2K | $74.6K | $395.1K | $55.0K |
| Total liabilities | n/a | $86.6K | $278.2K | $39.7K |
| Shareholders' equity | $119.2K | -$12.1K | $116.9K | $15.2K |
| Return on year-end equity | -125.6% | n/a | -807.1% | -155.1% |
| Shares outstanding | 25.44M | 82.61M | 27.94M | 25.91M |
Revenue, most recent five fiscal years
| Fiscal year | Bodhi Tree Biotechnology Inc | Wenyuan Group Corp. | Hestia Insight Inc. | Radiant Strategies Corp |
|---|---|---|---|---|
| Latest | $17.0K Ended 2025-09-30 | $24.6K Ended 2025-12-31 | $8.0K Ended 2025-11-30 | $40.3K Ended 2026-04-30 |
| 1 year earlier | n/a | $60.3K Ended 2024-12-31 | $1.25M Ended 2024-11-30 | n/a |
| 2 years earlier | n/a | $21.1K Ended 2023-12-31 | $113.4K Ended 2023-11-30 | n/a |
| 3 years earlier | n/a | $41.1K Ended 2022-12-31 | $15.0K Ended 2022-11-30 | n/a |
| 4 years earlier | n/a | n/a | $28.5K Ended 2021-11-30 | n/a |